DYSFIP1 activators are a class of chemicals designed to enhance the function of DYSFIP1, a protein that plays a pivotal role in cellular processes. The identification and development of these activators require a comprehensive understanding of the protein's structure, its interaction partners within the cell, and the pathways it influences. Researchers utilize various high-throughput screening techniques to sift through extensive libraries of compounds, searching for those that can increase the activity of DYSFIP1. This screening process often involves the use of reporter assays, where the activation of DYSFIP1 leads to a quantifiable signal, allowing for the rapid identification of potential activators. Subsequent structure-activity relationship (SAR) studies are crucial for understanding how the chemical structure of these compounds affects their ability to activate DYSFIP1, enabling chemists to modify and optimize the compounds for increased efficacy and specificity.
Once potential activators are identified, further experiments are conducted to elucidate their mechanism of action. This involves detailed biochemical assays to examine how these compounds interact with DYSFIP1 at the molecular level, including binding studies and kinetic analyses to assess how they influence the protein's activity. Advanced techniques such as X-ray crystallography or nuclear magnetic resonance (NMR) spectroscopy may be employed to determine the three-dimensional structure of the protein in complex with the activator, providing insights into the molecular basis for activation. Additionally, cellular assays are utilized to confirm that the activation observed in vitro translates to a functional increase in DYSFIP1 activity within cells. These studies not only help in refining the understanding of DYSFIP1's role in cellular pathways but also guide the iterative optimization of DYSFIP1 activators, ensuring that they are both effective and selective. Through these methodical approaches, researchers aim to develop a robust class of DYSFIP1 activators that can modulate the protein's activity with precision, contributing to the broader understanding of cellular regulation mechanisms.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Ionomycin | 56092-82-1 | sc-3592 sc-3592A | 1 mg 5 mg | $78.00 $270.00 | 80 | |
Facilitates calcium influx, potentially influencing muscle membrane repair processes involving DYSFIP1. | ||||||
Brefeldin A | 20350-15-6 | sc-200861C sc-200861 sc-200861A sc-200861B | 1 mg 5 mg 25 mg 100 mg | $31.00 $53.00 $124.00 $374.00 | 25 | |
Disrupts transport within the Golgi apparatus, potentially affecting vesicle trafficking and DYSFIP1 function. | ||||||
L-α-Lecithin, Egg Yolk, Highly Purified | 8002-43-5 | sc-203096 | 250 mg | $135.00 | ||
A component of cell membranes, involved in signaling processes relevant to muscle biology and membrane repair. | ||||||
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Activates adenylate cyclase, increasing cAMP levels and potentially influencing pathways involving DYSFIP1. | ||||||
Cytochalasin D | 22144-77-0 | sc-201442 sc-201442A | 1 mg 5 mg | $165.00 $486.00 | 64 | |
Inhibits actin filament polymerization, potentially influencing vesicle trafficking and DYSFIP1 function. | ||||||
(S)-(−)-Blebbistatin | 856925-71-8 | sc-204253 sc-204253A sc-204253B sc-204253C | 1 mg 5 mg 10 mg 25 mg | $72.00 $265.00 $495.00 $968.00 | ||
Inhibits myosin II, potentially impacting muscle cell dynamics and processes involving DYSFIP1. | ||||||
Jasplakinolide | 102396-24-7 | sc-202191 sc-202191A | 50 µg 100 µg | $184.00 $305.00 | 59 | |
Stabilizes actin filaments, which could indirectly influence muscle cell functions and DYSFIP1 activity. | ||||||
Dynamin Inhibitor I, Dynasore | 304448-55-3 | sc-202592 | 10 mg | $89.00 | 44 | |
Inhibitor of dynamin, involved in vesicle scission, potentially impacting DYSFIP1-related vesicle trafficking. | ||||||
Nocodazole | 31430-18-9 | sc-3518B sc-3518 sc-3518C sc-3518A | 5 mg 10 mg 25 mg 50 mg | $59.00 $85.00 $143.00 $247.00 | 38 | |
A microtubule destabilizer, potentially affecting cellular dynamics relevant to DYSFIP1 in muscle cells. | ||||||
AICAR | 2627-69-2 | sc-200659 sc-200659A sc-200659B | 50 mg 250 mg 1 g | $65.00 $280.00 $400.00 | 48 | |
Activates AMP-activated protein kinase, potentially influencing metabolic pathways and muscle cell functions involving DYSFIP1. | ||||||